Clinical research investigating the reproductive effects of GLP-1 receptor agonists in women with PCOS reveals a notably consistent pattern of benefit, in contrast to the more ambiguous mechanistic and animal evidence [46]. This evidence concerns the gene GLP1R and polycystic ovary syndrome.